AI vs. doctors: the race to spot deadly skin cancer
NCT ID NCT06999499
Summary
This study is developing and testing artificial intelligence (AI) software designed to help detect potential melanoma skin cancers. The AI will analyze 3D whole-body scans of 1,000 adults with many moles, looking for suspicious spots. Researchers will compare how well the AI performs against the assessments of three expert dermatologists to see if it can be a reliable tool for early detection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAEVI are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital de la Conception
Marseille, 13005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.